IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i5p4637-d1088940.html
   My bibliography  Save this article

Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare

Author

Listed:
  • Robert J. Brent

    (Department of Economics, Fordham University, Bronx, NY 10458, USA)

Abstract

Cost-effectiveness analysis (CEA) is the main way that economic evaluations are carried out in the health care field. However, CEA has limited validity in deciding whether any health care evaluation is socially worthwhile and hence justifies funding. Cost-Benefit Analysis (CBA) is the economic evaluation method that should be used to help decide what to invest in when the objective is to record the impact on everyone in society. Cost-utility analysis (CUA), which has its roots in CEA, can be converted into CBA under certain circumstances that are not general. In this article, the strengths and weaknesses of CEA relative to CBA are analyzed in stages, starting in its most classical form and then proceeding via CUA to end up as CBA. The analysis takes place mainly in the context of five actual dementia interventions that have already been found to pass a CBA test. The CBA data is recast into CEA and CUA terms in tabular form in order that the contrast been CEA and CBA is most transparent. We find that how much of the fixed budget that is used up to fund other alternatives determines how much is left over to fund the particular intervention one is evaluating.

Suggested Citation

  • Robert J. Brent, 2023. "Cost-Benefit Analysis versus Cost-Effectiveness Analysis from a Societal Perspective in Healthcare," IJERPH, MDPI, vol. 20(5), pages 1-12, March.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:5:p:4637-:d:1088940
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/5/4637/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/5/4637/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Joseph E. Aldy & W. Kip Viscusi, 2008. "Adjusting the Value of a Statistical Life for Age and Cohort Effects," The Review of Economics and Statistics, MIT Press, vol. 90(3), pages 573-581, August.
    2. Pei-Jung Lin & Brittany D’Cruz & Ashley A. Leech & Peter J. Neumann & Myrlene Sanon Aigbogun & Dorothee Oberdhan & Tara A. Lavelle, 2019. "Family and Caregiver Spillover Effects in Cost-Utility Analyses of Alzheimer’s Disease Interventions," PharmacoEconomics, Springer, vol. 37(4), pages 597-608, April.
    3. Robert Brent, 2011. "An implicit price of a DALY for use in a cost-benefit analysis of ARVs," Applied Economics, Taylor & Francis Journals, vol. 43(11), pages 1413-1421.
    4. Brent, Robert J., 1991. "A new approach to valuing a life," Journal of Public Economics, Elsevier, vol. 44(2), pages 165-171, March.
    5. Johannesson, Magnus, 1995. "The relationship between cost-effectiveness analysis and cost-benefit analysis," Social Science & Medicine, Elsevier, vol. 41(4), pages 483-489, August.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. David Bardey & Philippe de Donder & Vera Zaporozhets, 2024. "The Health Technology Assessment Approach of the Economic Value of Diagnostic Tests - A Literature Review," Working Papers hal-04472485, HAL.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. James Hammitt, 2013. "Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures," Journal of Risk and Uncertainty, Springer, vol. 47(3), pages 311-325, December.
    2. Robert J. Brent, 2010. "Setting Priorities for HIV/AIDS Interventions," Books, Edward Elgar Publishing, number 12742.
    3. Ryan Edwards, 2013. "The cost of uncertain life span," Journal of Population Economics, Springer;European Society for Population Economics, vol. 26(4), pages 1485-1522, October.
    4. James K. Hammitt, 2020. "Valuing mortality risk in the time of COVID-19," Journal of Risk and Uncertainty, Springer, vol. 61(2), pages 129-154, October.
    5. Laura Muñoz-Bermejo & María José González-Becerra & Sabina Barrios-Fernández & Salvador Postigo-Mota & María del Rocío Jerez-Barroso & Juan Agustín Franco Martínez & Belén Suárez-Lantarón & Diego Muño, 2022. "Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer’s Disease," IJERPH, MDPI, vol. 19(22), pages 1-16, November.
    6. Moreno Gigi & van Eijndhoven Emma & Benner Jennifer & Sullivan Jeffrey, 2017. "The Long-Term Impact of Price Controls in Medicare Part D," Forum for Health Economics & Policy, De Gruyter, vol. 20(2), pages 1-56, December.
    7. Gre[ss], Stefan & Niebuhr, Dea & Rothgang, Heinz & Wasem, Jurgen, 2005. "Criteria and procedures for determining benefit packages in health care: A comparative perspective," Health Policy, Elsevier, vol. 73(1), pages 78-91, July.
    8. Alberto Chong & Marco Gonzalez-Navarro & Dean Karlan & Martín Valdivia, 2020. "Do Information Technologies Improve Teenagers’ Sexual Education? Evidence from a Randomized Evaluation in Colombia," The World Bank Economic Review, World Bank, vol. 34(2), pages 371-392.
    9. Kuhn, Michael & Frankovic, Ivan & Wrzaczek, Stefan, 2017. "Medical Progress, Demand for Health Care, and Economic Performance," VfS Annual Conference 2017 (Vienna): Alternative Structures for Money and Banking 168249, Verein für Socialpolitik / German Economic Association.
    10. Jytte Nielsen & Susan Chilton & Michael Jones-Lee & Hugh Metcalf, 2010. "How would you like your gain in life expectancy to be provided? An experimental approach," Journal of Risk and Uncertainty, Springer, vol. 41(3), pages 195-218, December.
    11. David Canning, 2007. "Valuing Lives Equally and Welfare Economics," PGDA Working Papers 2707, Program on the Global Demography of Aging.
    12. Anna Scherbina, 2021. "Assessing the Optimality of a COVID Lockdown in the United States," Economics of Disasters and Climate Change, Springer, vol. 5(2), pages 177-201, July.
    13. Cropper, Maureen L. & Joiner, Emily & Krupnick, Alan, 2023. "Revisiting the Environmental Protection Agency's Value of a Statistical Life," RFF Working Paper Series 23-30, Resources for the Future.
    14. Agamoni Majumder & S. Madheswaran, 2017. "Compensating wage differential and value of statistical life: a meta-analysis," The Indian Journal of Labour Economics, Springer;The Indian Society of Labour Economics (ISLE), vol. 60(4), pages 527-548, December.
    15. Borgschulte, Mark & Vogler, Jacob, 2020. "Did the ACA Medicaid expansion save lives?," Journal of Health Economics, Elsevier, vol. 72(C).
    16. James K. Hammitt & Jin-Tan Liu & Jin-Long Liu, 2022. "Is survival a luxury good? Income elasticity of the value per statistical life," Journal of Risk and Uncertainty, Springer, vol. 65(3), pages 239-260, December.
    17. Zahran, Sammy & Iverson, Terrence & McElmurry, Shawn P. & Weiler, Stephan & Levitt, Ryan, 2019. "Hidden Costs of Blight and Arson in Detroit: Evidence From a Natural Experiment in Devil's Night," Ecological Economics, Elsevier, vol. 157(C), pages 266-277.
    18. Martin Gaynor & Nirav Mehta & Seth Richards-Shubik, 2023. "Optimal Contracting with Altruistic Agents: Medicare Payments for Dialysis Drugs," American Economic Review, American Economic Association, vol. 113(6), pages 1530-1571, June.
    19. Churchill, Brandyn F., 2021. "How important is the structure of school vaccine requirement opt-out provisions? Evidence from Washington, DC's HPV vaccine requirement," Journal of Health Economics, Elsevier, vol. 78(C).
    20. Laura Armey & Thomas J. Kniesner & John D. Leeth & Ryan Sullivan, 2022. "Combat, casualties, and compensation: Evidence from Iraq and Afghanistan," Contemporary Economic Policy, Western Economic Association International, vol. 40(1), pages 66-82, January.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:5:p:4637-:d:1088940. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.